DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced U.S. Food and Drug Administration (FDA) 510(k) ...
Baxter International Inc. has scored FDA clearance for an infusion pump used to deliver small amounts of fluid at low rates, often in pediatric, neonatal and anesthesia care settings. The Novum Iq ...
NEW YORK (MarketWatch) -- Baxter International Inc.'s BAX, -2.55% Baxter Healthcare unit said Thursday the Food and Drug Administration has seized about 6,000 of its Colleague volumetric infusion ...
Baxter’s efforts this summer to correct high-risk issues with its infusion pumps has gotten more complicated. Last month, the company and the FDA alerted the public to a problem with the large-volume ...
Baxter International Inc. Thursday settled U.S. Justice Department allegations that two of its popular medication delivery pumps were flawed and violated federal law. In a 30-page agreement approved ...
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced CE marking and regulatory approval from Australia’s ...
Furthers Baxter’s continued innovation in medication delivery and management Integrates Baxter’s decades of leadership in infusion therapy with innovative digital health solutions to build on the ...
New addition to Baxter’s Evo IQ Infusion Platform complements on-market large volumetric pump, offering opportunity to further help personalize treatment Incorporates web-based Dose IQ Safety Software ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback